Financial News
Sarepta Therapeutics (NQ: SRPT )
144.24
-3.32
(-2.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Press Releases about Sarepta Therapeutics
![](https://ml.globenewswire.com/media/745335af-3a3a-4fb5-84c0-fdedc9adf092/small/july-30-2021-rosen-logo-jpg.jpg)
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
![](https://mms.businesswire.com/media/20231102269533/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Sarepta Therapeutics to Present at the UBS Biopharma Conference
November 02, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20231101211984/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20231031312403/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20231031074958/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
![](https://mms.businesswire.com/media/20231030875867/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20231025578048/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20230929375520/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230925062932_are-gene-therapy-stocks-the-markets-next-big-winne.jpg)
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://www.marketbeat.com/logos/articles/med_20230908091904_insiders-are-buying-these-2-stocks.jpg)
![](https://mms.businesswire.com/media/20230907578056/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20230905612978/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20230831155353/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20230802787677/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20230731018836/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20230726643986/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20230705080072/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20230703166327/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://mms.businesswire.com/media/20230630286511/en/1815332/5/Sarepta_Corporate-_Stacked_Logo_%28Full_Color%29.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230627075714_sarepta-therapeutics-gets-fda-nod-drops-warning-or.jpg)
![](https://mms.businesswire.com/media/20230622454844/en/1825449/5/Elevidys_Day_1_RGB.jpg)
![](https://mms.businesswire.com/media/20230531006020/en/448979/5/Sarepta_Therapeutics_Logo.jpg)
![](https://mms.businesswire.com/media/20230523006142/en/448979/5/Sarepta_Therapeutics_Logo.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230517121722_analysts-say-these-2-mid-cap-biotechs-have-2x-pote.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230516050346_sarepta-soars-31-as-fda-panel-backs-muscular-dystr.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.